Yen-Ju Chan Selected Research

Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)

1/2023	Activation of aryl hydrocarbon receptor by azatyrosine-phenylbutyric hydroxamide inhibits progression of diabetic retinopathy mice.
9/2021	Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR Degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yen-Ju Chan Research Topics

Disease

2	Brain Edema (Cerebral Edema) 11/2019 - 10/2019
1	Hypoxia (Hypoxemia) 01/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2021
1	Body Weight (Weight, Body) 07/2020
1	Lung Neoplasms (Lung Cancer) 04/2012

Drug/Important Bio-Agent (IBA)

2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 09/2021
2	GoldIBA 11/2019 - 10/2019
2	Caveolin 1IBA 11/2019 - 10/2019
2	Protein Kinases (Protein Kinase)IBA 11/2019 - 10/2019
2	Aquaporin 1IBA 11/2019 - 10/2019
1	LipofuscinIBA 01/2023
1	beta-(5-hydroxy-2-pyridyl)alanineIBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2020
1	pycnidioneIBA 04/2012